Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT04830007
Other study ID # NOCONTRAIVG
Secondary ID 2021-A00298-33
Status Suspended
Phase
First received
Last updated
Start date November 2022
Est. completion date November 2022

Study information

Verified date January 2022
Source Centre Hospitalier Intercommunal Creteil
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study will be offered to all women who are consultant for an abortion plan are seen in consultation at the orthogeny center where the study will be conducted. Of these 700 women, about 10% will not agree to participate in the study and 10% will not meet the inclusion criteria. Thus it's plane to include 560 patients in the study.


Description:

In 1967, the Neuwirth law allowed women to control their fertility by establishing the right to contraception as a principle. Since then, they have continued to take ownership of the various contraceptive methods, which are regularly renewed. Contraceptive coverage is important in France as it is estimated that 92% of women of childbearing age use a contraceptive method. The pill remains the most widely used method of contraception (36.5%), ahead of the intrauterine device (25.6%) condoms (15.5%) Several laws have been introduced from 1967 to today to facilitate access to sexual health care: screening for sexually transmitted infections, free provision of emergency contraception to minors, non-prescription delivery of emergency contraception, free consultation at a family planning and education center, voluntary termination of pregnancy 100%, reimbursement of condoms by social security. Despite all the measures put in place, it is now clear that the number of unplanted pregnancies is decreasing slightly and the number of abortion has remained stable since 2001. According to the latest literature data, several socio-demographic factors appear to play a role in the rate of use of voluntary termination of pregnancy., including age, socio-cultural level, marital and economic status and ethnic origin. All the more striking, it appears that while voluntary termination of pregnancy are mainly related to contraceptive failures, one third of them involve women who do not have contraception. According to the latest Ined survey, and in accordance with other data from the literature, the factors associated with the absence of contraceptive use are multiple: ignorance about fertility, family or cultural context, cost of contraceptive methods or lack of information related to them. While these studies have looked at the reasons given by women for the lack of contraception, with little data on the characteristics of these women, particularly socio-demographics and their reproductive history and in particular in the context of unwanted pregnancy. This finding leads us to question the factors associated with the absence of contraception among women in demand of a voluntary termination of pregnancy.


Recruitment information / eligibility

Status Suspended
Enrollment 560
Est. completion date November 2022
Est. primary completion date November 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - woman of 18 years of age or older; - Being French-speaking; - request for a medical or instrumental voluntary termination of pregnancy - No opposition to participation in the protocol - Be affiliated with a social security plan Exclusion Criteria: - desired pregnancy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHI Villeneuve St Georges Villeneuve-Saint-Georges

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Intercommunal Creteil

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Association between absence of contraception and socio-demographic factors, characteristics of pregnancy abortion and medical follow-up Statistically significant association between the absence of contraception in patients consulting for a voluntary termination of pregnancy and socio-demographic factors, characteristics of voluntary termination of pregnancy abortion and characteristics related to medical follow-up 1 hour
Secondary Prescription and dispensing of contraception Prevalence of patients informed about the prescription and dispensing of contraception including emergency contraception 1 hour
Secondary Existence of family planning centers Prevalence of patients informed about the existence of family planning centers 1 hour
Secondary Emergency contraception Prevalence of women who have used emergency contraception 1 hour
Secondary Price and reimbursement of condoms Prevalence of women informed about the price and reimbursement of condoms 1 hour
Secondary Knowledge of conception Estimate the percentage of women who thought they could get pregnant at the time of the intercourse that led to this pregnancy 1 hour
Secondary Fertile window Prevalence of women who use a method to track their fertile window 1 hour
Secondary Affection of fertility Estimate the percentage of women who think that contraception can affect their fertility 1 hour
See also
  Status Clinical Trial Phase
Terminated NCT03774745 - Blocking Mifepristone Action With Progesterone Phase 1/Phase 2
Completed NCT02447029 - Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial Phase 3